These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17303204)

  • 41. A structural perspective of the flavivirus life cycle.
    Mukhopadhyay S; Kuhn RJ; Rossmann MG
    Nat Rev Microbiol; 2005 Jan; 3(1):13-22. PubMed ID: 15608696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleic acid-based inhibition of flavivirus infections.
    Stein DA; Shi PY
    Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.
    Nickells J; Cannella M; Droll DA; Liang Y; Wold WS; Chambers TJ
    J Virol; 2008 Dec; 82(24):12510-9. PubMed ID: 18842715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vero cells infected with vaccinia viruses expressing Japanese encephalitis virus envelope protein induce polykaryocyte formation under neutral conditions.
    Konishi E; Yagawa K; Yamanaka A
    Jpn J Infect Dis; 2008 Sep; 61(5):410-1. PubMed ID: 18806356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness.
    Ni H; Barrett AD
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1449-55. PubMed ID: 8757986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes.
    Beasley DW; Morin M; Lamb AR; Hayman E; Watts DM; Lee CK; Trent DW; Monath TP
    Virus Res; 2013 Sep; 176(1-2):280-4. PubMed ID: 23602827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advancement in flavivirus vaccine development.
    Chang GJ; Kuno G; Purdy DE; Davis BS
    Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
    Leyssen P; De Clercq E; Neyts J
    Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability.
    Liang JJ; Liao CL; Liao JT; Lee YL; Lin YL
    Vaccine; 2009 May; 27(21):2746-54. PubMed ID: 19366580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Broad-spectrum inhibitor of viruses in the Flaviviridae family.
    Ojwang JO; Ali S; Smee DF; Morrey JD; Shimasaki CD; Sidwell RW
    Antiviral Res; 2005 Nov; 68(2):49-55. PubMed ID: 16199098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42.
    Lin CW; Cheng CW; Yang TC; Li SW; Cheng MH; Wan L; Lin YJ; Lai CH; Lin WY; Kao MC
    Virus Res; 2008 Oct; 137(1):49-55. PubMed ID: 18588927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological properties of chimeric West Nile viruses.
    Borisevich V; Seregin A; Nistler R; Mutabazi D; Yamshchikov V
    Virology; 2006 Jun; 349(2):371-81. PubMed ID: 16545851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties.
    Chambers TJ; Nestorowicz A; Mason PW; Rice CM
    J Virol; 1999 Apr; 73(4):3095-101. PubMed ID: 10074160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication.
    Brault JB; Kudelko M; Vidalain PO; Tangy F; Desprès P; Pardigon N
    Virology; 2011 Sep; 417(2):369-78. PubMed ID: 21767858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.
    Widman DG; Ishikawa T; Fayzulin R; Bourne N; Mason PW
    Vaccine; 2008 May; 26(22):2762-71. PubMed ID: 18423946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of robust antiviral assays for profiling compounds against a panel of positive-strand RNA viruses using ATP/luminescence readout.
    Gong E; Ivens T; Van den Eynde C; Hallenberger S; Hertogs K
    J Virol Methods; 2008 Jul; 151(1):121-5. PubMed ID: 18433887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fitness of Japanese encephalitis virus to Neuro-2a cells is determined by interactions of the viral envelope protein with highly sulfated glycosaminoglycans on the cell surface.
    Chiou SS; Liu H; Chuang CK; Lin CC; Chen WJ
    J Med Virol; 2005 Aug; 76(4):583-92. PubMed ID: 15977230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
    Lee E; Pavy M; Young N; Freeman C; Lobigs M
    Antiviral Res; 2006 Jan; 69(1):31-8. PubMed ID: 16309754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.
    Ishikawa T; Widman DG; Bourne N; Konishi E; Mason PW
    Vaccine; 2008 May; 26(22):2772-81. PubMed ID: 18433947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.